TrumpRx Now Offers Over 60 Discounted Medications: How to Buy Step by Step
Posted on 04/10/26 at 13:11
Two of the most important pharmaceutical companies in the United States will expand the availability of discounted drugs on the TrumpRx platform starting this Monday, according to information confirmed by CBS News.
These companies are AbbVie and Genentech, which become the tenth and eleventh firms to join this program promoted by the administration of Donald Trump.
- Why it matters: The initiative aims to reduce the cost of prescription drugs for people without health insurance, a group that often faces the highest prices in the U.S. healthcare system—making TrumpRx discount medications especially relevant.
More Discounted Medications on TrumpRx
With the addition of AbbVie and Genentech, the TrumpRx platform significantly expands its catalog of TrumpRx discount medications.
The site now offers more than 60 medications at reduced prices, compared to about 40 when it launched in February. This expansion reflects growing interest from manufacturers in participating in this discount model.
AbbVie, which reached an agreement with the administration in January, will begin offering Humira, one of the most widely used drugs for treating conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.

Humira Discounts of Up to 86%
The case of Humira is particularly significant due to its high cost.
The price of the Humira Pen (adalimumab) can exceed $6,900 for uninsured patients. However, through TrumpRx, coupons will reduce that cost to approximately $950.
This represents a discount of nearly 86%, according to agreements with the White House—highlighting the impact of TrumpRx discount medications.
These prices apply only to individuals without insurance or whose plans do not cover these medications. Insured patients typically pay less through their coverage.
Genentech Lowers Prices for Flu Medications
Another major development is the addition of Genentech, which will offer the medication Xofluza.
This treatment, used to prevent and treat influenza, will be priced at around $50, down from $168, according to the White House.
The price reduction is part of negotiated agreements within the TrumpRx program to expand access to common treatments through TrumpRx discount medications.

Amgen Expands Its Offerings
In addition to the new participants, Amgen is expanding its presence on the platform.
New additions include Enbrel, used to treat arthritis, and Otezla, used for plaque psoriasis.
These moves further establish TrumpRx as a growing channel for accessing TrumpRx discount medications.
How TrumpRx Works and Who Can Use It
TrumpRx does not directly sell medications. Instead, it functions as a platform that displays discounted offers.

Users can access these prices through coupons presented at participating pharmacies or via manufacturers’ websites.
No account or registration is required. However, patients must have a valid prescription and consult their doctor beforehand.
The program is intended for individuals paying out of pocket. Those enrolled in government programs such as Medicare or Medicaid cannot use these discounts.
Additionally, users cannot request reimbursements or apply these purchases toward insurance deductibles when using TrumpRx discount medications.
YOU MAY ALSO BE INTERESTED IN: IRS Increases Retirement Savings Limits: What Latino Workers Need to Know
What’s Next: More Medications Could Be Added
The White House has indicated that not all medications are yet available on TrumpRx, but the catalog is expected to continue growing.
The program’s expansion will depend on new agreements with pharmaceutical companies and adoption by patients.
For now, the platform’s growth represents a new effort to reduce drug costs in the United States, especially for those facing the highest prices without insurance—making TrumpRx discount medications an increasingly important resource.